Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form
Reexamination Certificate
2011-04-12
2011-04-12
Acevedo, James H Alstrum (Department: 1616)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Particulate form
C514S167000, C514S169000, C514S579000, C514S659000, C514S728000, C514S774000, C514S776000, C514S781000, C514S947000, C514S951000
Reexamination Certificate
active
07923032
ABSTRACT:
The invention provides compositions and methods for treating a subject who has suffered from a central nervous system disorder. More particularly, the invention provides sustained polymeric drug delivery systems having a polymer particle, a therapeutic agent, and a buoyancy agent for direct delivery of therapeutic agents into the central nervous system.
REFERENCES:
patent: 5354934 (1994-10-01), Pitt et al.
patent: 5455044 (1995-10-01), Kim et al.
patent: 5560933 (1996-10-01), Soon-Shiong et al.
patent: 5576018 (1996-11-01), Kim et al.
patent: 5814607 (1998-09-01), Patton
patent: 5814666 (1998-09-01), Green et al.
patent: 6123956 (2000-09-01), Baker
patent: 6306439 (2001-10-01), Penners et al.
patent: 2003/0059476 (2003-03-01), Wang
patent: 2003/0129233 (2003-07-01), Vook et al.
patent: 2003/0138486 (2003-07-01), Ouadji
patent: WO 94/26250 (1994-11-01), None
Oxford Pocket American Dictionary of Current English, Oxford University Press: New York, 2002, p. 97.
CRC Handbook of Chemistry and Physics, 84th ed. 2003-2004, pp. 3-306 and 3-307.
Brown, T. L. Chemistry: The Central Science, 6th ed. Prentice Hall: Englewood Cliffs, NJ, 1994, p. 18.
Russell et al. “Allogenic Blood Stem Cells and Bone Marrow Transplantation for Acute Myelogenous Leukemia and Myelodysplasia: Influence of Stem Cell Source on Outcome,” Bone Marrow Transplantation, 1999, 24, 1177-1183.
CRC Handbook of Chemistry and Physics, 75th edition, CRC Press: Boca Raton, 1994-1995, pp. 4-50.
Harris, D.C. Quantitative Chemical Analysis, 4th ed., W. H. Freeman and Co.: 1995, pp. 26.
Merriam-Webster's Collegiate Dictionary, 10thedition, Merriam-Webster, Inc.: Springfield, Massachusetts, 1996, pp. 152.
“Density of Cooking Oil” accessed on Aug. 19, 2010 at hypertextbook.com/facts/2000/IngaDorfman.shtml.
Misra et al. “Incorporation of vitamin E in poly(3hydroyxbutyrate)/Bioglass composite films: effect on surface properties and cell attachment,” J.R. Soc. Interface, 2009, vol. 6, pp. 401-409.
Estebe et al., “Prolongation of Spinal Anesthesia with Bupivacaine-Loaded (DL-Lactide) Microsheres,”Anesth Analg, (1995), 81:99-103.
Jeong et al., “Thermosensitive sol-gel reversible hydrogels,”Advance Drug Delivery Reviews, (2002), 54:37-51.
Lee et al., “Development of oral drug delivery system using floating microspheres”,Journal of Microencapsulation, (1999), 16(6):715-7299.
Lee et al., “Effect of adding non-volatile oil as a core material for the floating microspheres prepared by emulsion solvent diffusion method,”Journal of Microencapsulation, (2001), 18(1):65-75.
Zentner et al., “Biodegradable block copolymers for delivery of proteins and water-insoluble drugs,”Journal of Controlled Release, (2001), 72:203-215.
EP Search Report, Jun. 12, 2009, EP.
Adibhatla, et al.,J. Neurochem., 80(1):12-23 (2002).
Agut, et al.,Arzneitm, Forsch. Drug Res., 33(II):1045-1047 (1983).
Bawa, et al.,J. Controlled Release, 1:259-267 (1985).
Benowitz, et al.,J. Biol. Chem., 273(45):29626-29634 (1998).
Brem, et al.,J. Neurosurg., 74:441-446 (1991).
Brown, et al.,J. Pharm. Sci., 72(10):1181-1185, Oct. 1983.
Camarata, et al.,Neurosurg., 30(3):313-319 (1992).
Chen, et al.,Proc. Natl. Acad. Sci. USA, 99(13):9031-9036 (2002).
Fresta, et al.,Pharm. Res., 12(11):1769-1774 (1995).
Goodell, et al.,Am. J. Hospital Pharm., 43(6):1454-1461 (1986).
Göppferich, A.,Marcomolecules, 30(9):2598-2604 (1997).
Grill, et al.,J. Neurosci., 17(14):5560-5572 (1997).
Hansch, et al.,J. Med. Chem., 11(1):1-11 (1967).
Harbaugh, R.E.,Psychopharmacol. Bulletin, 22(1):106-109 (1986).
Hatcher, et al.,Soc. Neurosci., Abstract only, 25:583 (1999).
Hentze, et al.,Rev. Mol. Biotech., 90(1):27-53 (2002).
Kammersgaard, et al.,Stroke, 31:2251-2256 (2000).
Kawashima, et al.,J. Controlled Release, 16(3):279-289 (1991).
Langer, et al.,J. Macromol. Sci.—Rev. Macromol. Chem. Phys., C23(1):61-126 (1983).
Langer, et al.,in Biomedical Polymers, polymeric materials and pharmaceuticals for biomedical useGoldberg, E.P., Nakagim, A. (eds.), Academic press, pp. 113-137 (1980).
Langer, R.,J. Controlled Release, 16(1-2):53-59 (1991).
Lazorthes, et al.,in Advances in Drug Delivery Systems and Applications in Neurosurgery, 18:143-192 (1991).
Lee, et al.,J. Microencapsualtion, 18(1):65-75 (2001).
Lee, et al.,J. Microencapsualtion, 16(6):715-729 (1999).
Lexin, et al.,Anesthesia and Analgesia, 60(11):814-817 (1981).
Menei, et al.,Neurosurg., 34(6):1058-1064 (1994).
Noor, et al.,Med. Sci. Monit., 8(9):RA210-RA215 (2002).
Ommaya, A.K.,Cancer Drug Delivery, 1(2):169-179 (1984).
Petrausch, et al.,J. Neurosci., 20(21):8031-8041 (2000).
Rao, et al.,J. Neurosci. Res., 58(5):697-705 (1999).
Rhine, et al.,J. Pharm. Sci., 69(3):265-270 (1980).
Secades, et al.,Meth. Find. Exp. Clin. Pharmacol., 17Suppl. B):1-54 (1995).
Weiss, G.B.,Life Sci., 56(9):637-660 (1995).
Winn, et al.,Experimental Neurol., 105(3):244-250 (1989).
Baker Keith
MacAusland Samuel S.
Pratt Daniel
Acevedo James H Alstrum
Mintz Levin Cohn Ferris Glovsky and Popeo P.C.
Seacoast Neuroscience, Inc.
LandOfFree
Buoyant polymer particles for delivery of therapeutic agents... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Buoyant polymer particles for delivery of therapeutic agents..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Buoyant polymer particles for delivery of therapeutic agents... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2698922